14 research outputs found
Recommended from our members
Some schemes for on-line correction of the closed orbit, dispersion and beta functions in PEP
PEP has been operated successfully under computer control. It is necessary for colliding beam operation that the errors in closed orbits, dispersion and beta functions be corrected. The schemes in the PEP control program for on-line correction of these errors are described in this paper. The orbit control tasks in the PEP control system perform the functions of data gathering, data presentation (color display, printing), calculation and setting of corrector magnets. The tasks are generally small and modular, taking information from the database, processing it, then returning the results to the database. The PEP operator communicates with the tasks through touch panels monitored by the Director program. The display task, which displays orbit and corrector information on a TV color display, provides the main information required by the operator
Kinetic modeling of tumor growth and dissemination in the craniospinal axis: implications for craniospinal irradiation
BACKGROUND: Medulloblastoma and other types of tumors that gain access to the cerebrospinal fluid can spread throughout the craniospinal axis. The purpose of this study was to devise a simple multi-compartment kinetic model using established tumor cell growth and treatment sensitivity parameters to model the complications of this spread as well as the impact of treatment with craniospinal radiotherapy. METHODS: A two-compartment mathematical model was constructed. Rate constants were derived from previously published work and the model used to predict outcomes for various clinical scenarios. RESULTS: The model is simple and with the use of known and estimated clinical parameters is consistent with known clinical outcomes. Treatment outcomes are critically dependent upon the duration of the treatment break and the radiosensitivity of the tumor. Cross-plot analyses serve as an estimate of likelihood of cure as a function of these and other factors. CONCLUSION: The model accurately describes known clinical outcomes for patients with medulloblastoma. It can help guide treatment decisions for radiation oncologists treating patients with this disease. Incorporation of other treatment modalities, such as chemotherapy, that enhance radiation sensitivity and/or reduce tumor burden, are predicted to significantly increase the probability of cure
Primary spinal cord tumors of childhood: effects of clinical presentation, radiographic features, and pathology on survival
To determine the relationship between clinical presentation, radiographic features, pathology, and treatment on overall survival of newly diagnosed pediatric primary spinal cord tumors (PSCT). Retrospective analysis of all previously healthy children with newly diagnosed PSCT at a single institution from 1995 to present was performed. Twenty-five pediatric patients (15 boys, average 7.9Â years) were diagnosed with PSCT. Presenting symptoms ranged from 0.25 to 60Â months (average 7.8Â months). Symptom duration was significantly shorter for high grade tumors (average 1.65Â months) than low grade tumors (average 11.2Â months) (PÂ =Â 0.05). MRI revealed tumor (8 cervical, 17 thoracic, 7 lumbar, 7 sacral) volumes of 98â94,080Â mm3 (average 19,474Â mm3). Homogeneous gadolinium enhancement on MRI correlated with lower grade pathology (PÂ =Â 0.003). There was no correlation between tumor grade and volume (PÂ =Â 0.63) or edema (PÂ =Â 0.36) by MRI analysis. Median survival was 53Â months and was dependent on tumor grade (PÂ =Â 0.05) and gross total resection (PÂ =Â 0.01) but not on gender (PÂ =Â 0.49), age of presentation (PÂ =Â 0.82), duration of presenting symptoms (PÂ =Â 0.33), or adjuvant therapies (PÂ =Â 0.17). Stratified KaplanâMeier analysis confirmed the association between degree of resection and survival after controlling for tumor grade (PÂ =Â 0.01). MRI homogeneous gadolinium enhancement patterns may be helpful in distinguishing low grade from high grade spinal cord malignancies. While tumor grade and gross total resection rather than duration of symptoms correlated with survival in our series, greater than one-third of patients had reported symptoms greater than 6Â months duration prior to diagnosis
Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience
Conventional therapy for intracranial germinomas is craniospinal irradiation. In 1990, the SociĂ©tĂ© Française d'Oncologie PĂ©diatrique initiated a study combining chemotherapy (alternating courses of etoposideâcarboplatin and etoposideâifosfamide for a recommended total of four courses) with 40 Gy local irradiation for patients with localized germinomas. Metastatic patients were allocated to receive low-dose craniospinal radiotherapy. Fifty-seven patients were enrolled between 1990 and 1996. Forty-seven had biopsy-proven germinoma. Biopsy was not performed in ten patients (four had diagnostic tumour markers and in six the neurosurgeon felt biopsy was contraindicated). Fifty-one patients had localized disease, and six leptomeningeal dissemination. Seven patients had bifocal tumour. All but one patient received at least four courses of chemotherapy. Toxicity was mainly haematological. Patients with diabetus insipidus (n = 25) commonly developed electrolyte disturbances during chemotherapy. No patient developed tumour progression during chemotherapy. Fifty patients received local radiotherapy with a median dose of 40 Gy to the initial tumour volume. Six metastatic patients, and one patient with localized disease who stopped chemotherapy due to severe toxicity, received craniospinal radiotherapy. The median follow-up for the group was 42 months. Four patients relapsed 9, 10, 38 and 57 months after diagnosis. Three achieved second complete remission following salvage treatment with chemotherapy alone or chemo-radiotherapy. The estimated 3-year survival probability is 98% (CI: 86.6â99.7%) and the estimated 3-year event-free survival is 96.4% (CI: 86.2â99.1%). This study shows that excellent survival rates can be achieved by combining chemotherapy and local radiotherapy in patients with non-metastatic intracranial germinomas. © 1999 Cancer Research Campaig